Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
$6.22B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
$2.98B |
| 3 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
$2.66B |
| 4 |
Apple
AAPL
|
$790M |
| 5 |
Microsoft
MSFT
|
$769M |
Top Sells
| 1 |
Vanguard Real Estate ETF
VNQ
|
$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$244M |
| 3 |
Oracle
ORCL
|
$214M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
$140M |
Sector Composition
| 1 | Technology | 23.63% |
| 2 | Financials | 12.75% |
| 3 | Consumer Discretionary | 9.87% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Corvus Pharmaceuticals
CRVS
$422M
| $160K | ﹤0.01% |
29,968
+14,300
| +91% | +$76.5K |
|
3352
ClearPoint Neuro
CLPT
$296M
| $159K | ﹤0.01% |
10,369
| – | – |
|
3353
HilleVax
HLVX
$104M
| $156K | ﹤0.01% |
75,596
| – | – |
|
3354
Delcath Systems
DCTH
$381M
| $156K | ﹤0.01% |
+12,977
| New | +$156K |
|
3355
Forafric Global
AFRI
$221M
| $155K | ﹤0.01% |
15,141
+3,204
| +27% | +$32.8K |
|
3356
Ovid Therapeutics
OVID
$87.5M
| $151K | ﹤0.01% |
161,808
| – | – |
|
|
SERV
3357
Serve Robotics
SERV
$634M
| $151K | ﹤0.01% |
+11,183
| New | +$151K |
|
3358
MediciNova
MNOV
$64.3M
| $150K | ﹤0.01% |
71,506
| – | – |
|
3359
Prelude Therapeutics
PRLD
$64M
| $149K | ﹤0.01% |
117,200
-16,049
| -12% | -$20.5K |
|
3360
Flotek Industries
FTK
$359M
| $148K | ﹤0.01% |
+15,581
| New | +$148K |
|
3361
McEwen Inc.
MUX
$746M
| $146K | ﹤0.01% |
18,704
| – | – |
|
3362
Atomera
ATOM
$101M
| $145K | ﹤0.01% |
12,488
| – | – |
|
|
CLPR
3363
Clipper Realty
CLPR
$70.4M
| $145K | ﹤0.01% |
31,569
| – | – |
|
3364
Tilly's
TLYS
$54M
| $144K | ﹤0.01% |
33,968
-9,759
| -22% | -$41.5K |
|
|
AKYA
3365
DELISTED
Akoya BioSciences
AKYA
| $144K | ﹤0.01% |
63,002
| – | – |
|
|
ATYR
3366
aTyr Pharma
ATYR
$554M
| $144K | ﹤0.01% |
39,689
+13,000
| +49% | +$47.1K |
|
3367
FerroAtlántica
GSM
$771M
| $141K | ﹤0.01% |
37,098
-39,080
| -51% | -$149K |
|
|
GOOS
3368
Canada Goose Holdings
GOOS
$1.27B
| $141K | ﹤0.01% |
14,003
-14,171
| -50% | -$142K |
|
3369
FibroBiologics
FBLG
$26M
| $139K | ﹤0.01% |
69,732
| – | – |
|
3370
Myomo
MYO
$40.1M
| $138K | ﹤0.01% |
21,495
| – | – |
|
3371
Shattuck Labs
STTK
$48.4M
| $138K | ﹤0.01% |
114,139
| – | – |
|
3372
Abeona Therapeutics
ABEO
$351M
| $133K | ﹤0.01% |
23,850
| – | – |
|
3373
Personalis
PSNL
$427M
| $133K | ﹤0.01% |
22,941
| – | – |
|
|
AGEN
3374
Agenus
AGEN
$133M
| $131K | ﹤0.01% |
47,954
-8,000
| -14% | -$21.9K |
|
3375
Blue Ridge Bankshares
BRBS
$373M
| $131K | ﹤0.01% |
+40,597
| New | +$131K |
|